The agreement , which was reached between Bristol-Myers and Christopher J. Christie , the United States attorney in Newark , lifts a cloud that has hung over the company since April 2002 , when Mr. Dolan announced that sales would be sharply lower than expected because wholesalers had been stocking excess inventories of its products .